University of Alabama in Huntsville

LOUIS
Honors Capstone Projects and Theses

Honors College

4-16-2021

Medication Adherence in Outpatient Pharmacies
Kylie Alissa Bain

Follow this and additional works at: https://louis.uah.edu/honors-capstones

Recommended Citation
Bain, Kylie Alissa, "Medication Adherence in Outpatient Pharmacies" (2021). Honors Capstone Projects
and Theses. 32.
https://louis.uah.edu/honors-capstones/32

This Thesis is brought to you for free and open access by the Honors College at LOUIS. It has been accepted for
inclusion in Honors Capstone Projects and Theses by an authorized administrator of LOUIS.

William S Wilkerson

Digitally signed by William S Wilkerson
Date: 2021.04.23 08:19:54 -05'00'

3

Table of Contents

Abstract............................................................................................................................................4
Introduction.....................................................................................................................................5
Review of Literature......................................................................................................................10
Theoretical Framework..................................................................................................................15
Methodology..................................................................................................................................17
Results............................................................................................................................................21
Limitations ....................................................................................................................................22
Discussion......................................................................................................................................22
Implications to Nursing Practice....................................................................................................25
Conclusion.....................................................................................................................................26
References .....................................................................................................................................27
Appendix A: Recruitment Flyer.....................................................................................................29
Appendix B: Demographic Questionnaire.....................................................................................30
Appendix C: Probabilistic Medication Adherence Scale Instrument............................................34
Appendix D: Qualtrics Survey Sample..........................................................................................35
Appendix E: Phone Script for Recruitment Calls..........................................................................42
Appendix F: Phone Script for Wellness Calls...............................................................................44
Appendix G: Final Experience Survey .........................................................................................45
Appendix H: IRB Approval Letter................................................................................................47
Table 1: Participant Adherence Scores..........................................................................................52
Table 2: Participant ProMAS Questionnaire Results.....................................................................53

4

Abstract
Background: On average, 50% of patients on a medication for a chronic condition are
nonadherent, meaning they do not take their medication as prescribed (Hilbink et al., 2016).
Nonadherence can have costly and deadly effects on patients and the healthcare system as a
whole. Multiple factors influence patients’ medication adherence behaviors, so patient care must
be examined at an individualized level in order to prevent future hospitalizations. Nurses are on
the frontline of healthcare and have the ability to prevent rehospitalizations. As such, nurses must
have a foundational understanding of the overall healthcare system to provide optimal education
for life after hospitalization. The purpose for this study was to survey patients’ medication
adherence behavior’s so nurses can better understand major deterrents of proper medication
adherence. This knowledge can improve hospital discharge teaching, community outreach, and
individualize patient-centered care. to prevent rehospitalizations.
Methods: Recruitment for the study was limited to flyers handed to patients within one
pharmacy (See Appendix A). Participants completed a demographic questionnaire and the
ProMAS per Qualtrics survey format or over the phone. Due to the barriers of Covid-19, in
person contact was restricted in order to follow CDC guidelines, governmental restrictions, and
reduce the risk of spreading the virus. Therefore, the study was significantly modified per
pharmacy necessity and details will be further explained in the following thesis.
Results: The Medication Adherence in Outpatient Pharmacies (MAiOP) study examined seven
outpatient pharmacy patient’s medication behaviors and demographics. The results indicated that
patients who have less barriers have higher medication adherence behaviors, meaning they take
their medication as prescribed and consequently should have lower incidences of hospitalization.
Discussion: The study was very limited due to small sample size and biased demographics, but
does illustrate the satisfactory use of the ProMAS. In ensuing studies, it is recommended to
expand upon the original study plan and use a larger sample size in order to gain wider variance
results.
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Introduction
New diagnoses and their resulting medications can be a life-altering change for people.
Adhering to a rigorous medication schedule is challenging to maintain, and can be worsened by
numerous barriers. On average, 50% of patients on medication for a chronic condition are
nonadherent, meaning they do not take their medication as prescribed (Hilbink et al., 2016).
Nonadherence can have costly and deadly effects on patients and the healthcare system as a
whole. Asymptomatic patients, such as those with high blood pressure and cholesterol, can be at
a higher risk for noncompliance because patients do not feel like they need to take their
medication often. The results of nonadherence for asymptomatic patients are unobservable until
major consequences occur that can require expensive hospital stays or result in unexpected
deaths. Numerous research studies show multiple ways nonadherent patients, including but not
limited to asymptomatic patients, may improve their medication regimen.
From the review of literature, it is apparent that medication adherence is a serious issue
that must be dealt with at an individualized level. Every person is different, and a personalized
approach to combat noncompliance may be crucial to reduce medication administration for the
betterment of the patients and the healthcare system.
Medication non-adherence poses a serious threat to nurses because nonadherent patients
are at risk for hospitalization and serious complications (Kleppe, Lacroix, Ham, & Midden,
2015). Nurses have to handle the increased patient admittance and potentially lethal
consequences from improper compliance. The increase in nurse and hospital workload causes
rising healthcare costs that ultimately affect standard patient care. Understaffing and work
inefficiency can cause issues for nurses’ health and wellbeing which will also place hardships on
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the delivery of conventional care. Nurses must recognize risks for non-adherence and provide
patient education to better promote adherence and prevent serious complications from arising
requiring hospitalization. A prophylactic intervention to reduce medication nonadherence is the
best way to combat the rising healthcare costs due to treatable chronic conditions. Understanding
the outpatient pharmacy aspects and implementing the proper techniques to promote better
medication compliance will decrease all the previously mentioned complications that arise in
nursing care.
Multiple research studies have been performed to better understand what prevents
individuals from medication persistence, and how to improve it. The most difficult part about
performing research studies to improve medication compliance is determining a proper tool to
measure the amount and timing of medication administration of individuals. The measurements
of medication adherence research studies are an issue to be dealt with to better understand
nonadherence and ameliorate medication compliance.
Medication adherence measuring for research studies has improved, but still faces many
challenges. Self-report and pill packaging sensors that monitor when and how many times
medication vials have been opened are the easiest and best way to measure medication
compliance (Kleppe et al., 2015). The practices are flawed, though, in that patient self-report are
not always accurate, and pill packaging sensors do not inform the researchers with the
amount/dosage taken each time the vial is opened. Patients may forget or falsify important
information that can alter study results.
Most medication adherence studies focus on how to improve measurement tools,
barriers, and patient motivation while a patient is taking a medication. While understanding and
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improving these methods is critical, healthcare workers should use this information to better
predict high risk patients and use this information to prevent patients from developing poor
habits. Predicting high risk, nonadherent patients, and developing personalized interventions and
communication techniques has been less studied and less implemented in outpatient pharmacies.
The purpose of this paper is to understand in pharmacy patients, over the age of 18 taking three
or more medications, does improved communication with outpatient pharmacy staff through use
of a risk assessment questionnaire improve medication adherence compared to patients with no
risk assessment? A risk assessment and personal profile can better improve pharmacy-patient
communication, and promote a consistent medication compliance schedule.
A main concern that is encountered with medication adherence is the multifaceted
barriers that can prevent individuals from adhering to their medication regimen (Hilbink et al.,
2016). Everyone has a slightly different reason preventing them from taking their medication,
rather it be money or simply forgetting to take it at a certain time every day. Due to the varied
situations (education level, job status, transportation to the pharmacy, living arrangements,
marital status) surrounding an individual’s nonadherence, a singular solution will not benefit
everyone (Mohd et al., 2016). Individuals who have to subcutaneously inject medication versus
an oral tablet will change the entire medication administration perspective. People who are
extremely symptomatic may adhere to their medication schedule more strictly than patients that
are asymptomatic. Nurses must understand the barriers that prevent individuals from complying
with the medication program so we can transfer it into a usable, reliable risk assessment that can
be

used

in

outpatient

pharmacies

to

promote

better

patient-pharmacy-practitioner

intercommunication and higher medication consistency. A risk assessment sheet that can define
deviating important circumstances to individualize patient care can improve patient contact and
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promote patient-centeredness. Then, patients can better adhere to their medication schedule with
improved motivation, education, and reminders.
The majority of research studies about medication adherence focused on measurement
tools (afore mentioned), behavioral patterns, and situational barriers that cause medication
adherence. It has been found that cost, specific diagnoses like psychological disorders or
asymptomatic diseases, and lack of education are some of the most common reasons patients are
nonadherent. The research was performed to understand the reasons behind nonadherence. It is
recommended these strategies be applied to outpatient pharmacies and general practitioner’s
offices to be more aware of the reasons and prevent the situations that may cause nonadherence.
Often, there are other drugs within the same class that can provide the same effects and be less
costly to the patient. The barriers can be combined to produce a profile risk assessment to make
pharmacy workers more aware of high-risk patients and contact them more frequently or
determine proper solutions to help them adhere to prescriptions.
Currently, outpatient pharmacies make hundreds of calls to patients daily who may not be
at risk, or for reasons that are unimportant. Some unimportant reasons to call patients may be for
acute medication physician refill calls or to offer refills for medications that are being filled by
mail order. A practical software for some patients can sync medication pickup together, but calls
to offer this service for patients taking controlled medications is inefficient. Controlled
medications can only be refilled and picked up at specific intervals. The more important patient
care calls that should be done include manufacturer coupons to lower medication costs,
medication side effects and questions, and medication adherence. Pharmacists and technicians
are overwhelmed with the number of prescriptions to fill and phone calls to make, so patient
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contact needs to become more efficient to be effective for medication adherence. Through the
use of a patient profile and risk assessment, pharmacies can better determine where to focus their
attention efficiently to improve medication adherence and patient satisfaction.
There has not been a specific evidence-based protocol designed for outpatient
pharmacies, rather every pharmacy determines specific reasons to call patients, normally based
on refill completion for increased pharmacy scoring. A new standard of care for medication
nonadherence is crucial for global medication regimen improvements and drastic decreases in
chronic disease mortality rates. Half of all U.S. adults state having at least one chronic condition,
mainly cardiovascular disease, which is the number one cause of mortality and morbidity
(Hilbink et al., 2016). Such high numbers of patients at risk for nonadherence and mortality
require a new standard of care to be implemented to decrease fatality rates and healthcare costs.
This study was developed based on the information discussed in the literature review and
the researcher’s experiences working in an outpatient pharmacy. The ProMAS tool is better
suited for wider variance and more adherence behaviors, and the demographic questions are
essential in order to have a clear picture of patients and determine the reasons behind medication
nonadherence. The demographics tool was developed (See Appendix B) and the ProMAS (See
Appendix C) was chosen as the tool for the study based on the literature review. The purpose for
this study was to survey patients’ medication adherence behavior’s so nurses can better
understand major deterrents of proper medication adherence.
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Review of Literature
The selected articles were found using the University of Alabama in Huntsville library,
PubMed database, and CINAHL database with inclusion criteria English language and peerreviewed articles published within the past six years. Some key words that were used to narrow
the search criteria included medication adherence education, medication adherence tools, and
individualization of medication adherence.
A quasi-experimental research study by Korkmaz, Tastan, and Pay (2016) demonstrated
that education is a large part of medication adherence by illustrating the effects of patient
education about administration of subcutaneous and intravenous injections. The Turkish
scientists aimed to increase the rates of medication adherence in rheumatoid patients when they
were provided with individualized education about their diagnosis, current medications, purpose
of treatment, drug usage, instructions on administration of the biologic drugs, adverse effects of
the drugs, and storage maintenance of the drugs. The sample population included 30 patients
administering subcutaneous injections and 30 patients receiving intravenous injections. They
found from baseline pre-test and post-test results measured after 3 months, that an individualized
education interview increased patients with a high knowledge level from 50% to 96.7% and the
motivation levels from 56.7% to 93.3% in subcutaneous injection patients measured on the
Morisky Medication Adherence Scale (MMAS or MMS) (Korkmaz et al., 2016). The MMAS is
a tool used to determine adherence behaviors and conclude how well patients adhered to their
medication regimen (Mohd, Phung, Sun, Morisky, 2016). The WHO-5 Well-Being Index was
used to give an indication on the quality of life of the participants receiving biologic drugs. The
means from both samples increased, approximately 4 points for the intravenous group and 9 for
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the subcutaneous group, illustrating a better quality of life after individualized education. The
limitations of this study include the focus on rheumatic disorders and biologic drugs from one
clinic and measurements taken after only 3 months. The study should be further tested with oral
medications in various settings and multiple diagnoses. Strengths of this study include in-depth
patient personal information, widely used and validated measurement tools, and statistically
significant data results.
Social support continues to play a key role for human functioning. It can be especially
important to patients battling chronic health conditions and requiring multiple doctor’s visits and
medications. There are three very important reasons to have social support for medication
adherence. First, emotional support is essential for those unwilling or unable to consistently take
prescribed medication. Second, patients may require help with some alternative medications
other than oral, such as injectables. Finally, transportation to and from the pharmacy when the
patients is unable. Pinto and Schub (2018) defined structural support as being available to
support someone and functional support as the actions that people take to provide the support.
Both of these types of support, listed in the meta-analysis evidenced-based care sheet, were
described as essential to increased adherence in multiple groups. Multiple statements within the
evidence-based care sheet concerning an increase of adherence are important jobs for registered
nurses to complete. These jobs included discharge teaching, identifying weaknesses and
strengths of patients’ support system, and providing the necessary tools to improve one’s support
system like information about support groups. Intercollaborative professional care between
nurses, pharmacists, and other health care providers will create the best possible outcome for
patient health. The strengths of the meta-analysis included the wide-range of data being pulled
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into a concise sheet, and the large amount of data considered. A weakness is that the sheet did
not provide much information for future research.
Mohd et al. (2016) also performed a study in which a 30-minute education session for
diabetic patients in the United Arab Emirates improved medication adherence a statistically
significant amount, also measured with the MMAS. The researchers had 446 patients partake in
the study from the police health clinic in Dubai, the 223 patients of the control group received
standard care and the 223 patients of the intervention group in the intervention group received
the education session and telephone interviews. Both sample groups completed the initial and
final 6-month MMAS questionnaire and blood tests. The control group’s MMAS scores
remained relatively constant throughout the study. The intervention arm’s scores increased in
high and medium adherence behaviors, 26.5% to 39.9% in medium adherence, and decreased
low adherence behaviors, 64.6% to 44.8%. The mean HbA1c also decreased significantly in the
intervention arm, and the control arm remained relatively constant. Some strengths of the study
include a large sample population, widely used and validated measurement tools, and statistically
significant data results. The limitations of the study are that it was performed at one police clinic
in Dubai on type-2 diabetic patients only covering 6 months. MMAS is only one tool being used
to study patient’s adherence behaviors, other tools include the Probabilistic Medication
Adherence Scale (ProMAS) and the Medication Adherence Report Scale (MARS).
Medication adherence measures remain the most difficult and focused issue in
compliance studies. The ProMAS and the MARS tools use a series of questions to measure
adherence behaviors. Kleppe et al. (2015) developed the ProMAS in a cross-sectional,
randomized controlled study comparing the MARS and ProMAS tools. The purpose of the study
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was to develop an improved tool to quantifiably measure self-reported medication adherence
behaviors. A recruitment agency randomly selected geriatric patients 65+ years of age in a Dutch
database who were then invited to partake in the study in exchange for agency points. 370
participants that took medication for chronic conditions were selected to participate in the study.
Both the MARS and ProMAS questionnaires were administered in a single online sitting, and the
results were compared. They determined that the ProMAS and MARS scores correlated, but that
the ProMAS allowed a higher variance to provide a wider range of adherence behaviors and
match patient’s behaviors more accurately. The strengths of this study included the random
selection of participants, large amount of information received from each singular online session,
and the large number of participants used. Some limitations included the possible bias from the
agency points payment for participation, the adaption of the educational tool/model, and that
some ProMAS items could not be widely used among varying diagnoses. The ProMAS needs
further testing and validation to overrule the widely accepted and used tool, MARS. With a
better tool to quantifiably measure adherence behaviors, it can be appropriately transferred into a
valuable risk assessment to prophylactically and continuously monitor nonadherence.
A singular study by Hilbink et al. (2016), was created using a personal profile based on
ProMAS and a barrier assessment questionnaire as a predictive measurement to tailor an
intervention protocol for high-risk adherence patients starting an oral blood glucose lowering or
cardiovascular medication in the Netherlands. The aim was to individualize patient contact and
care based on barrier profiles and questionnaires. Unfortunately, they have not completed their
cluster-randomized trial as of now and we cannot gain any insight into the successes and failures
of the trial. The researchers planned to administer the questionnaires at baseline, 8-months, and
1-year follow-ups to monitor progress. Some strengths from this article included the wide range
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of planned pharmacies being studied (25 and across different demographics), longer term study
of 1 year, the individualization among the patients with a profile, and the planned randomization
of participants. The limitations of the article are that the trial has either not been completed or the
results not published, the limit to diabetic and cardiovascular diagnoses, and the limit to beginner
medication patients. Now if researchers can translate these measuring tools to predictive
measures of nonadherence, we can better contact and review educational materials with higher
risk patients to decrease nonadherence and medical costs.
There is clear evidence that education and individualization can improve medication
adherence rates and in turn lower healthcare costs and healthcare worker inefficiency. Education
and individualization must be implemented to increase higher adherence rates and patientcenteredness. Social support must be established or improved in order for some patients to
maintain adherence. A patient will not understand the important reasons behind medication
compliance without proper education, and might not take their medication appropriately. Patients
then have to suffer with serious complications and expensive healthcare bills due to
nonadherence. When patients are unable to avoid complications as a result from the lack of
support, then patients may be less willing to participate in their own healthcare. Every patient has
specific reasons for not adhering to medication, so individualized patient care must be
implemented to satisfy all patients.

The significant increase of adherence behaviors and

motivation levels across all of the reviewed studies illustrates the importance of education on the
motivation levels and subsequent medication administration of patients.
Although education and individualization need to become priority, high output
pharmacies cannot manage total patient education and maintain proper refill requirements.
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Practitioners and nurses in primary care and hospital settings need to better educate patients
about the diagnosis and medications before pickup at outpatient pharmacies. Discharge education
about the use, side effects, and diagnosis need to be more thoroughly examined as well as patient
contact in outpatient pharmacies. It can become very costly for high output pharmacies to
implement such a radical change such as a risk assessment and prophylactic call system. As a
result of the implementation though, it could save the entire healthcare system millions of
dollars. The motivation to implement the changes will be difficult to establish in corporate
pharmacies that spread across the country, so private pharmacies may have a better chance
establishing new systems to improve medication adherence. Though there may be issues with
widespread outpatient pharmacy change, the implementation of individualized risk assessments
and prophylactic contact is clearly a direction that must be further tested and implemented to
ensure proper patient care and better medication adherence.
Theoretical Framework
The Neuman’s Systems Model may be applied to medication adherence in that healthcare
workers must address all of the variables that may cause patient’s stress and illness. UmeNwagbo, DeWan, and Lowry (2006) give a brief summary of Neuman’s Systems Model and
presents two hypothetical instances in which the theory may be applied. Neuman’s Model is a
centralized circle surrounded by numerous concentric circles that symbolize lines of resistance
(LOR) (See Figures, Illustrations, and Tables). The lines are penetrated by stress to eventually
affect the inner circle, that represents physiological features, and cause illness. The outer two
lines represent the flexible line of defense (FLD) and the normal line of defense (NLD), and are
shaped by several variables such as coping patterns. There are three different types of prevention
to protect the core structure; primary, secondary, and tertiary. Primary prevention reinforces the
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FLD to prevent stressors from infiltrating the NLD. Secondary prevention are measures taken
after the NLD has been infiltrated and must be restored. Tertiary prevention techniques involve
support to reinstitute the LOR and adapt to the permeating stressors. The first hypothetical case
focuses on a longstanding marriage where stressors have broken the NLD and LOR, and the
marriage must be rebuilt. The second hypothetical case involves a man in need of a coronary
artery bypass graft and the interventions a healthcare team must surpass to allow the patient to
safely undergo the procedure and heal accordingly afterwards.
The Neuman’s Systems Model

Medication adherence is similar to the concentric circles, being that multiple stressors
have caused illness and now the LOR and NLD must be rebuilt with the proper medication
schedule. Education and support (tertiary prevention) help patients to readapt to their new
circumstances following a rigorous medication regimen. After reconditioning, patients must
properly take their prescribed medications to properly maintain the NLD and prevent further
illness from occurring (secondary prevention). The multiple stressors include the numerous
barriers that prevent patients from following the proper prescription details, and allow the NLD
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to be permeated. Further reevaluation of diagnosis/medication education (primary prevention)
beyond first fill information and patient contact are crucial to maintain the support needed for
protecting the FLD. All patients are affected by different variables to restrict them from adhering
to medications, and personalized actions must occur to restore and maintain the NLD.
Methods
COVID-19 severely hampered the proceedings of the study. The original methodology
called for the used questionnaires to be given twice, once as a baseline and again for final data
collection and comparison. Originally data would have been collected in-person within the
pharmacy, by Qualtrics survey, and by over the phone recruitment. Contact was supposed to be
made with the participants over a 90-day period, the length of time between usual prescription
pickups, based on the ProMAS score obtained with baseline data. After the 90-day period, the
ProMAS questionnaire would have been readministered for comparison and analyzed for
effectiveness of contact. Due to the required reduction in patient interaction, methodology was
adjusted to minimize patient risks. Therefore, only baseline data was collected to encourage
participation and comply with pharmacy preferences and CDC guidelines.
Due to the recent public health events, contactless research has become essential. To
comply with CDC guidelines and governmental restrictions, Qualtrics surveys were made to
allow patients easy access to the questionnaires. If patients were uncomfortable with over the
phone confidentiality disclosure and the technological handling, then the option to mail and
return all research information and questionnaires was provided. IRB approval for the modified
methodology was procured by the University of Alabama in Huntsville on 1 August 2020 (See
Appendix H).
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Population, Sample and Setting
A convenience sample of participants was recruited for this research study. Participants
received information about the research study through flyers handed out within a single
pharmacy in Huntsville, Alabama. In order to have well-rounded data, a wide variance of
participants was sought because people of all demographic groups experience difficulty with
medication adherence for various reasons. Also, the goal was to illustrate that people within
different socioeconomical levels require individualized care. A wide age range was targeted,
over the age of 18, to obtain ample data. The sample size consisted of seven patients from an
outpatient pharmacy. They were all of Caucasian, non-Hispanic background with the majority
being male participants. Five of the seven participants were in the age range of 60-69 with two
outliers, one 80+ years old and the other between the age of 50-59. All participants earn $50,000
annually, most averaging over $100,000. Most participants reported a strong support system, and
the majority of participants have a spouse or partner and a personal vehicle for transport. All
participants have a collegiate degree, with four having a masters or other graduate degree. The
participants had to have a medication list of equal to or more than three maintenance medications
for chronic conditions to qualify for participation in the study. Participants did not have a
caregiver dedicated to medication pickup, and were be able to handle their medications and
ensuing information autonomously.
Data Collection
Data was mostly collected by the Qualtrics survey format per the URL and QR code on
the recruitment flyers distributed at the pharmacy (See Appendix A and D). Only two
participants chose to answer the questionnaires verbally over the phone. Per the original
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methodology, recruitment and wellness call phone scripts were developed for participant
interaction consistency (See Appendix E and F).
Research Design
The study is non-experimental with a convenience sample of patients from an outpatient
pharmacy. It does not have any comparison groups and therefore cannot qualify as a quasiexperimental experiment. This format was chosen to gain better insight from a small sample of
participants. In doing so, more information can be retrieved and a trend can be better identified
due to the sample being small. By breaking the sample into two groups for comparison with the
same sample size the data would not be able to demonstrate a significant trend. The data would
also be unable to demonstrate a significance between comparison groups with a seven-participant
sample size. Due to the extreme restrictions on the original research design caused by COVID19, a pilot study was performed in a small independent pharmacy. There have been multitudes of
research done on patient medication adherence with no alterations to pharmacy functioning. The
data will be compared with results that have been repeatedly tested in the conclusion of the
study.
Instruments
The participants completed two questionnaires. The demographic questions include basic
census questions along with questions about participants’ current medications, background,
conditions, and support system (See Appendix B). The information participants provided helps
pharmacists and technicians educate patients and confront any issues that lead to nonadherence.
The second questionnaire is the ProMAS tool developed by Kleppe, Lacroix, Ham, and Midden
(2015).
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The Probabilistic Medication Adherence (ProMAS) tool was used to have a wider
variance of adherence behaviors (See Appendix C). It is composed of 18 questions and was
created using Rasch analysis to place participants into low, medium-low, medium-high, and high
medication adherence scales. Rasch analysis allows researchers to place questionnaire answers of
unequal difficulty on a linear scale, meaning the ProMAS can better understand and interpret
medication adherence behaviors over the other commonly used scales such as the MARS
(Kleppe et al., 2015). Originally, the methodology of the study included contact with participants
formulated from the baseline score of the ProMAS instrument. To reference for future studies,
each category will have different amounts of participant-pharmacy contact requirements. The
low category will consist of wellness calls every 2 weeks. The medium categories’ wellness calls
will be performed every 3 weeks. The high category will be every 4 weeks, a common length of
a normal prescription.
The original research design was, after the study’s 90-day duration, the participants
would be asked the ProMAS questions again for comparison, and complete an experience survey
(See Appendix G). The experience survey asks about the participants medication adherence
evolution since the start of the survey and what they liked and disliked about the study. The
experience survey can be applied to any future research for further patient satisfaction.
Procedure
First, flyers were distributed at the pharmacy to disseminate information about the
research project and to recruit participants. Information was distributed to the population
previously described. The flyer contained the main researcher’s contact information so those that
were interested could contact by phone. Also, a Qualtrics’s QR code and URL was on the flyer
for patients who preferred to complete the information electronically. The baseline questionnaire
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and ProMAS tool were conducted over the phone and by Qualtrics URLs per the patient’s
preference, but the option to mail the questionnaires and have them returned was provided. All
participants gave consent before completing the questionnaires, include basic demographic
information and the ProMAS tool. The ProMAS tool evaluated the participants’ level of
medication adherence behavior. This is where the current, IRB approved study finished.
Results
The data received from the seven participants was meticulously analyzed for trends by
the main researcher. The study was maintained for four months to extend time for proper
recruitment and data gathering. All data was gathered per Qualtrics online format and by phone
as previously mentioned. The following trends were found for the small sample size, but further
testing is required to establish congruity with the population. The MAiOP is a pilot study that
must be further tested in appropriate settings to build strong evidence for a complete conclusion.
The following tables give an overall summary of the results for the ProMAS tool. Table 2
displays the results for each individual question of the ProMAS survey based on participant
answers. Table 1 illustrates the final medication adherence categories as analyzed from Table 2
data.
It took participants an average of 19 minutes to complete the surveys, across both data
collection platforms. The average ProMAS score was 12.57, which ranges in the medium-high
medication adherence category. Six of the seven participants took a cardiovascular medication
with an average of four of these medications for each participant. Four of the seven participants
take at least one allergy medication, and three of the participants take a gastrointestinal
medication. One trend observed was all participants who took cardiovascular medications also
took gastrointestinal medications. This may or may not be significant due to the fact that the
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majority of the participants took cardiovascular medications, and needs further research to verify
a significant trend. Also, it was observed that with increasing age a stronger support system is
needed for declining health but support systems seem to dwindle as age increases. Further
evaluation of the results will be discussed in the following sections of the paper.
Limitations
The MAiOP study was severely hampered by the COVID-19 pandemic. The original
design was significantly modified, and no face-to-face contact was permitted with any
participants. Due to the significant modifications of the original research design, this paper
covers the pilot study performed in lieu. No face-to-face recruitment was granted, so the sample
size is significantly small, limiting data analysis. The sample was also biased in that all
participants were from a single ethnicity/race, primarily one gender, from a high socioeconomic
level, and all from one small area in Huntsville, Alabama. The level of participant
comprehension could not be evaluated due to limited contact, so it was difficult to determine the
reliability of collected data.
Discussion
Although the data suggests trends exhibited by the seven participants, the MAiOP is a
pilot study and will need further testing in the future. Saying that, some significances were
discovered that could prove vital to future research. The average time taken to complete the two
surveys is 19 minutes, and this is a lengthy time period. The time required to complete the
surveys may have limited participation. In the future, hopefully more face-to-face interaction
will be allowed to reduce the stress of the lengthy surveys. Also, this would minimize the
ambiguity of participant answers and assure researchers of accurate data, while also reducing
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participant confusion. There was not enough data to suggest a significant trend in adherence
rates with increasing age due to the majority of participants being within the same age range.
The study was completed in northern Alabama and is significant due to common lifestyle
qualities. The CDC reports that 36.1% of people in Alabama are obese, most likely the result of
common diet and exercise trends for the area (2020). This significance influences the type of
medications required, and explains why six of the seven participants take cardiovascular
medications. Heart disease is the major leading cause of death, and from the researcher’s
personal experience, heart disease comes with numerous comorbidities and leads to a host of
complications. Also, northern Alabama has a very high pollen count as reported by the national
pollen map, so it is not surprising that the majority of participants took at least one allergy
medication (pollen.com, 2021).
Support systems are vital to human functioning, and the need increases with age and
declining health. The majority of study participants reported a proper support system, but some
did not. The older participants reported greater need for support, which illustrates that as
individuals’ age increases it becomes more difficult to maintain a proper support system. This is
due to a number of factors, one being the death of friends and family but is also due to the
increasing need of support with declining health. It is not explicitly important for the MAiOP
research study, but improved geriatric programs could significantly reduce the difficulties that
come with increased age such as falls and memory loss. On the same note this could improve
medication adherence and reduce hospitalizations ultimately.
Insurance is a complicated matter that, from the researcher’s personal experience, is
ultimately misunderstood and requires education. The participants voiced concerns about the
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confusion of federal and private insurance matters. Medicare Part B seems to be distinctly
confusing and requires education for prescription and medical coverage. It is suggested that a
future study be performed for education about federal and private insurance policies to study the
effects of this type of education on hospitalization and medication adherence. The majority of
participants had high level degrees, so confusion about insurance policies is quite significant.
Also, the U. S Department of Health and Human Services reports that only 12% of adults have
proficient health literacy (2008). While the participants have high levels degrees, it is unknown
to their level of health literacy knowledge, especially when little to no time was allowed to be
spent with the participants. In a future reapplication of the MAiOP study, it is recommended to
include demographics questions about types of insurance and level of understanding.
In the original pre-pandemic research design, baseline data would have been collected
multiple ways to determine adherence behaviors. The main researcher was going to call
prospective participants in order to more effectively recruit participants, but was unable to per
pharmacy concerns. Normally, participants would have been able to talk to the main researcher
in the pharmacy or call for any information. For future research, the ProMAS data would have
been analyzed and determined the level of contact with each patient. Some patients with lowerlevel medication adherence behaviors would be contacted more frequently, whereas, those with
high levels would be contacted less frequently. Contact with the participants would continue at
regular intervals per the protocol determined for 90 days. This duration was chosen because it is
the general prescription length for maintenance medications. After the 90 days, the ProMAS tool
used for baseline data would be administered once again to obtain baseline data. A comparison
of the final data with the baseline data would ensue to determine whether the contact protocol
improved medication adherence.
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Implications to Nursing Practice
The MAiOP pilot study may not illustrate significant trends that can be applied to the
population, but medication adherence is critical for nursing practice and the toll it takes on the
healthcare system. Hospitalizations can be extremely taxing on the patients, patient families, and
hospital systems. High medication adherence reduces hospitalizations and the impediments for
patients. Detailed and understandable medication education must be given not only in outpatient
pharmacies but also in inpatient discharge teaching and outpatient follow-ups. Nurses must take
on this critical task to improve health outcomes and reduce complications. Education for
patients should be individualized to accommodate those that lack proper health literacy and agerelated memory alterations.
Increasing age comes with increased health risks, complications, and reduced support
system. Education is vital throughout the lifespan to reduce the complications that arise with age
advancement. Nurses should evolve with the ever-evolving technology and advance healthcare
practices for the entire lifespan to ensure holistic patient-centered care. Geriatric patients are at a
high risk for falls and reduced support, so medication adherence also declines with decreased
abilities. Nurses can reduce nonadherence by applying appropriate support measures such as
home healthcare, support groups, exercise/diet programs, and involving the appropriate familial
connections. Holistic patient-centered care has become the gold standard for nurses, and as such
individualized care should be given for patients in all settings to improve overall health and
decrease healthcare costs.

26

Conclusion
Medication adherence is vital to excellent patient well-being and nurses should be aware
of the gravity of it. The MAiOP was merely a pilot study that was unable to detect significant
trends in data, but is an excellent source for future research and study development. The original
design should be tested and implemented to produce sound data analysis and hopeful increases in
adherence rates. The ProMAS was tested further to verify its accuracy of predicting medication
adherence behaviors. Patient interaction is crucial for the production of an adequate an
appropriate model of the original research design. As already discussed, the data does hint
towards improved adherence rates with economically and educationally settled individuals,
which correlates with past research. Future research needs to focus on the implementation of a
standardized assessment tool in outpatient pharmacies and the collaboration of pharmacy staff
with inpatient/outpatient nurses. This in itself would reduce immense confusion and create
rounded patient-centered care. Recommendations for alterations to the original MAiOP research
design would be to include demographic questions about insurance and medication names to
have a better correlation between specific medications such as cardiovascular and acid reflux
medications. Registered nurses must be educated and able to easily assess important factors that
would restrict proper adherence behaviors. They must also work with the healthcare team and
act as a leader and advocate to ensure the best possible patient-centered care.

27

References
Adult obesity prevalence maps. (2020, September 21).
https://www.cdc.gov/obesity/data/prevalence-maps.html.
Alabama Allergy Map. POLLEN.COM. (n.d.). https://www.pollen.com/map/al.
America’s Health Literacy: Why We Need Accessible Health Information. An Issue Brief from
the U.S. Department of Health and Human Services. 2008.
https://www.ahrq.gov/sites/default/files/wysiwyg/health-literacy/dhhs-2008-issuebrief.pdf.
Betty Neuman: Grand Theorist. (n.d.). Retrieved from
https://sites.google.com/site/bettyneuman1/.
Dimatteo, M. (2004). Social Support and Patient Adherence to Medical Treatment: A MetaAnalysis.

Health

Psychology,

23(2),

207–218.

https://doi.org/10.1037/0278-

6133.23.2.207
Hilbink, M., Lacroix, J., Bremer-van Der Heiden, L., van Halteren, A., Teichert, M., & van
Lieshout, J. (2016). Effectiveness of a medication-adherence tool: study protocol for a
randomized controlled trial. Trials, 17(1), 274. https://doi.org/10.1186/s13063-016-13932.
Kleppe, M., Lacroix, J., Ham, J., & Midden, C. (2015). The development of the ProMAS: A
Probabilistic Medication Adherence Scale. Patient Preference and Adherence, 9, 355–
367. https://doi.org/10.2147/PPA.S76749.
Korkmaz, S., Tastan, S., & Pay, S. (2016). The Effect of Individualized Drug Education on
Medication Adherence among Patients Using Biologic Drugs. International Journal of

28

Caring Sciences, 9(3), 965–974. Retrieved from
http://search.proquest.com/docview/1860631925/.
Mohd, M., Phung, H., Sun, J., & Morisky, D. (2016). Improving adherence to medication in
adults with diabetes in the United Arab Emirates. BMC Public Health, 16(1), 1–11.
https://doi.org/10.1186/s12889-016-3492-0.
Ume-Nwagbo, P., Dewan, S., & Lowry, L. (2006). Using the Neuman Systems Model for Best
Practices. Nursing Science Quarterly, 19(1), 31–35.
https://doi.org/10.1177/0894318405284125.

29

Appendix A
Recruitment Flyer

30

Appendix B
Demographic Questionnaire
-----Beginning of Questionnaire----ID (leave blank): ________________

Date of birth/Age: _____________ Gender: _____

Address (zip code/city is enough if uncomfortable with full address):
______________________________________________________________________________
______
Email: __________________________________ Phone # (needed) ____________________

What is your preferred method of contact from the pharmacy for refill reminders on
maintenance medications?
Text Message Reminders

Patient Call Reminders from a Technician

Medications that you are currently taking and approximate length you have been taking
them:
1. __________________________

6. __________________________

2. __________________________

7. __________________________

3. __________________________

8. __________________________

4. __________________________

9. __________________________

5. __________________________

10. __________________________

If applicable, list the other medications at the end of the questionnaire.
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List any/all chronic health conditions (see previous definition if needed):
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

Describe your own understanding of the chronic condition(s):
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________

Level of education (circle one):
Never attended high school

Some college

College Degree:

Some high school

College Degree:

Bachelor’s Graduate

GED

Associate’s

Degree

High school diploma

Average annual salary (circle one):
<$25,000

$50,000-$75,000

$25,000-$50,000

$75,000-$100,000

>$100,000
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Transportation (circle one):
Within walking distance of

Bus/public transportation

pharmacy

No ability to leave the

Personal vehicle

home

Friend/family drives you

Marital status (circle one):
Single

Have a partner/spouse

Support system (list any members):
Family: ___________________________________
Friends: __________________________________
Do you feel that you have an appropriate support system for your needs? (circle one):
Definitely yes

Undecided

Probably yes

Probably not

Definitely not

If applicable for injections and topicals medications: Do you have the ability to administer your
own medications or do you require someone to help you? (circle one): Yes, I need help
No, I do not need help
If so then who? ______________________________

or
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What is your race? (circle one):
American Indian or Alaska Native

Native Hawaiian or Other Pacific Islander

Asian

White

Black or African American

What is your ethnicity? (circle one):
Hispanic or Latino or Spanish origin

Not Hispanic or Latino or Spanish origin

-----End of Questionnaire-
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Appendix C
Probabilistic Medication Adherence Scale Instrument
It has happened at least once that I forgot to take (one of) my
medicines. (R)
1. It happens occasionally that I take (one of) my medicines at a
later moment than usual. (R)
2. I have never (temporarily) stopped taking (one of my) medicines.

Y or N

3. It has happened at least once that I did not take (one of) my
medicines for a day. (R)
4. I am positive that I have taken all the medication that I should
have taken in the previous year.
5. I take my medicines exactly at the same time every day.

Y or N

6. I have never changed my medicine use myself.

Y or N

7. In the past month, I forgot to take my medicine at least once. (R)

Y or N

8. I faithfully follow my doctor’s prescription concerning the
moment of taking my medicines.
9. I sometimes take (one of) my medicines at a different moment
than prescribed (eg, with breakfast or in the evening). (R)
10. In the past, I once stopped taking (one of) my medicines
completely. (R)
11. When I am away from home, I occasionally do not take (one of)
my medicines. (R)
12. I sometimes take less medicine than prescribed by my doctor. (R)
13. It has happened (at least once) that I changed the dose of (one of)
my medicines without discussing this with my doctor. (R)
14. It has happened (at least) once that I was too late with filling a
prescription at the pharmacy. (R)
15. I take my medicines every day.

Y or N

16. It has happened (at least once) that I did not start taking a
medicine that was prescribed by my doctor. (R)

Y or N

17. I sometimes take more medicines than prescribed by my doctor.
(R)

Y or N

Y or N
Y or N

Y or N
Y or N

Y or N
Y or N
Y or N
Y or N
Y or N
Y or N
Y or N

36

37

38

39

40

41

42

Appendix E
Phone Script for Recruitment Calls
Researcher Recruitment Calls to Participants
Anything in the brackets is said if the call does not go to voicemail.
<if the participant is unable to answer the phone then go straight from “pharmacy”
into the “I would…” researcher script and skip all participant script responses.>
Hello, this is _____________ from _______ Pharmacy. [How are you today]?
<participant replies similarly to “I’m doing well”>
[Good!] I would like to talk to you about a research study I am conducting within the
pharmacy. I am an (undergraduate nursing student) performing a medication adherence
project and am looking for willing participants. [It won’t require much of your time. May
I give you more information?] If you think you may be interested or have any questions
then give me a call back at _____________ for more information. Thank you for your
time.
---End of voicemail-----Continue if not a voicemail--<they may at this point say they are not interested. If so then say “That’s fine.”
respond “Thank you for letting me have a moment of your time, have a great day”>
<if they are interested and ask for more information proceed with script>
The study requires zero in-person contact unless you prefer to complete it in the
pharmacy. I do understand that all patients are concerned with the recent public health
events, and I can easily perform this study through a phone or electronic device. It only
consists of 2 questionnaires at the beginning and the end of the study with a few calls in
between. There is no risk to you and all personal information that you wish to provide
will remain strictly confidential and secured within a locked file. If at any time you wish
to not proceed with the study then there is zero recourse. All of your voluntary time is
simply to provide information to produce a better way to contact patients and improve
medication adherence. I want to better understand patients and the restrictions that
prevent them from properly taking their medication. In order to do so I want to
individualize patient care and allow patients to have more influence in their healthcare.

<again, they may at this point say they are not interested. If so then say “That’s fine.
Thank you for letting me have a moment of your time, have a great day>
<if they want are willing to participate proceed with script>
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Great! There are several ways for you to complete the 2 questionnaires. One way is for
me to go through both of them over the phone and you may answer or reject to answer
any questions I ask. Another way to answer them is to go to the URLs on Google Chrome
or any internet source you prefer and fill out the Qualtrics Survey format. Also, you can
always answer the questions in pharmacy, or I can even mail you the questionnaires to fill
out and return. If so, I would prefer you contact me at ____________ to ensure I can
perform the study at your preferred time.
<if they then and there want to perform the questionnaires over the phone, begin
asking the questions. If they want to perform the online survey then repeat the
URLs and tell them to have a nice day and call back at ___________ if they have any
questions. If they want to complete the questionnaires in pharmacy or at a later time
ask for an appropriate time to call them back or give a good time for them to call
you>
<if they never respond/call back/come to the pharmacy, follow up 1x to ensure they
did not just forget about you>
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Appendix F
Phone Script for Wellness Calls
Researcher Wellness Calls to Participants
Anything in the brackets is said if the call does not go to voicemail.
<if the participant is unable to answer the phone then go straight from “study” into
the “I am…” researcher script and skip all participant script responses.>
Hello, this is Kylie Bain from _____ Pharmacy and UAH College of Nursing. I am
performing the medication adherence research study. [How are you today]?
<participant replies similarly to “I’m doing well”>
[Good!] I am just calling for a wellness check to see how taking your medications have
been going and ask if you have any questions about anything. [If you have any questions
for the pharmacist, I will gladly redirect you to talk to her/him.]
<here they will reply and ask any questions>
<if they did not answer then say “If you do have any questions or concerns you may
give me a call back at ______________”>
---End of voicemail-----Continue if not a voicemail with participant questions and responses---
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Appendix G
Final Experience Survey
1. What did you like about this study?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

2. What did you not like about this study?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

3. What part(s) of the study was helpful to you for medication adherence?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

4. What part(s) of the study was not helpful to you for medication adherence?
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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5. Do you feel like you have a better understanding of your medications and conditions?
Explain.
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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Expedited: form 2
Clinical studies of drugs and medical devices only when condition (a) or (b) is met. (a)
Research on drugs for which an investigational new drug application (21 CFR Part 312) is not
required. (Note: Research on marketed drugs that significantly increases the risks or decreases
the acceptability of the risks associated with the use of the product is not eligible for expedited
review. (b) Research on medical devices for which (i) an investigational device exemption
application (21 CFR Part 812) is not required; or (ii) the medical device is cleared/approved for
marketing and the medical device is being used in accordance with its cleared/approved labeling.
Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows:
(a) from healthy, nonpregnant adults who weigh at least 110 pounds. For these subjects, the
amounts drawn may not exceed 550 ml in an 8-week period and collection may not occur more
frequently than 2 times per week; or (b) from other adults and children, considering the age,
weight, and health of the subjects, the collection procedure, the amount of blood to be collected,
and the frequency with which it will be collected. For these subjects, the amount drawn may not
exceed the lesser of 50 ml or 3 ml per kg in an 8-week period and collection may not occur more
frequently than 2 times per week.
Prospective collection of biological specimens for research purposes by noninvasive means.
Examples: (a) hair and nail clippings in a nondisfiguring manner; (b) deciduous teeth at time of
exfoliation or if routine patient care indicates a need for extraction; (c) permanent teeth if routine
patient care indicates a need for extraction; (d) excreta and external secretions (including sweat);
(e) uncannulated saliva collected either in an unstimulated fashion or stimulated by chewing
gumbase or wax or by applying a dilute citric solution to the tongue; (f) placenta removed at
delivery; (g) amniotic fluid obtained at the time of rupture of the membrane prior to or during
labor; (h) supra- and subgingival dental plaque and calculus, provided the collection procedure is
not more invasive than routine prophylactic scaling of the teeth and the process is accomplished
in accordance with accepted prophylactic techniques; (i) mucosal and skin cells collected by
buccal scraping or swab, skin swab, or mouth washings; (j) sputum collected after saline mist
nebulization.
Collection of data through noninvasive procedures (not involving general anesthesia or
sedation) routinely employed in clinical practice, excluding procedures involving x-rays or
microwaves. Where medical devices are employed, they must be cleared/approved for
marketing. (Studies intended to evaluate the safety and effectiveness of the medical device are
not generally eligible for expedited review, including studies of cleared medical devices for new
indications).
Research involving materials (data, documents, records, or specimens) that have been
collected, or will be collected
solely for nonresearch purposes (such as medical treatment or diagnosis).
Collection of data from voice, video, digital, or image recordings made for research purposes.
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X Research on individual or group characteristics or behavior (including, but not limited to,
research on perception, cognition, motivation, identity, language, communication, cultural
beliefs or practices, and social behavior) or research employing survey, interview, oral history,
focus group, program evaluation, human factors evaluation, or quality assurance methodologies.
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Exempt form 3:
Research conducted in established or commonly accepted educational settings, involving
normal educational practices, such as (a) research on regular and special education instructional
strategies, or (b) research on the effectiveness of or the comparison among instructional
techniques, curricula, or classroom management methods. The research is not FDA regulated and
does not involve prisoners as participants.
Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement),
survey procedures, interviews, or observation of public behavior 1 in which information is
obtained in a manner that human subjects cannot be identified directly or through identifiers
linked to the subjects and any disclosure of the human subject’s responses outside the research
would NOT place the subjects at risk of criminal or civil liability or be damaging to the subject’s
financial standing, employability, or reputation. The research is not FDA regulated and does not
involve prisoners as participants.
Research involving the use of educational tests (cognitive, diagnostic, aptitude, achievement)
survey procedures, interview procedures, or observation of public behavior if (a) the human
subjects are elected or appointed public officials or candidates for public office, or (b) Federal
statute(s) require(s) without exception that the confidentiality of the personally identifiable
information will be maintained throughout the research and thereafter. The research is not FDA
regulated and does not involve prisoners as participants.
Research involving the collection or study of existing data, documents, records, pathological
specimens, or diagnostic specimens, if these sources are publicly available or if the information
is recorded by the investigator in such a manner that subjects cannot be identified, directly or
through identifiers linked to the subjects. The research is not FDA regulated and does not involve
prisoners as participants.
Research and demonstration projects which are conducted by or subject to the approval of
department or agency heads, and which are designed to study, evaluate, or otherwise examine: (i)
public benefit or service programs; (ii) procedures for obtaining benefits or services under those
programs;(iii) possible changes in or alternatives to those programs or procedures; or (iv)
possible changes in methods or levels of payment for benefits or services under those programs.
The protocol will be conducted pursuant to specific federal statutory authority; has no statutory
requirement for IRB review; does not involve significant physical invasions or intrusions upon
the privacy interests of the participant; has authorization or concurrent by the funding agency and
does not involve prisoners as participants.
Taste and food quality evaluation and consumer acceptance studies, (i) if wholesome foods
without additives are consumed or (ii) if a food is consumed that contains a food ingredient at or
below the level and for a use found to be safe, or agricultural chemical or environmental
contaminant at or below the level found to be safe, by the Food and Drug Administration or
approved by the Environmental Protection Agency or the Food Safety and Inspection Service of
the U.S. Department of Agriculture. The research does not involve prisoners as participants.
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1 Surveys, interviews, or observation of public behavior involving children cannot be exempt.
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Table 1 Participant Adherence Scores
Adherence Category
Low

ProMAS Sum
Scores
0-4

MAiOP frequency
(number of patients)
N=0

Medium-Low

5-9

N=0

Medium-High

10-14

N=5

High

15-18

N=2
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Table 2 Participant ProMAS Questionnaire Results
ProMAS Question

Participants
Answering Yes

Participants
Answering No

1. It has happened at least once
that I forgot to take (one of) my
medicines. (R)

N=5

N=2

2. It happens occasionally that I
take (one of) my medicines at a
later moment than usual. (R)

N=5

N=2

3. I have never (temporarily)
stopped taking (one of my)
medicines.

N=4

N=3

4. It has happened at least once
that I did not take (one of) my
medicines for a day. (R)

N=6

N=1

5. I am positive that I have taken
all the medication that I should
have taken in the previous year.

N=4

N=3

6. I take my medicines exactly at
the same time every day.

N=4

N=3

7. I have never changed my
medicine use myself.

N=5

N=2

8. In the past month, I forgot to
take my medicine at least once.
(R)

N=3

N=4

9. I faithfully follow my doctor’s
prescription concerning the
moment of taking my
medicines.

N=7

N=0

10. I sometimes take (one of) my
medicines at a different moment
than prescribed (eg, with
breakfast or in the evening). (R)

N=0

N=7
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11. In the past, I once stopped
taking (one of) my medicines
completely. (R)
12. When I am away from home, I
occasionally do not take (one
of) my medicines. (R)

N=1

N=7

N=2

N=5

13. I sometimes take less medicine
than prescribed by my doctor.
(R)

N=0

N=7

14. It has happened (at least once)
that I changed the dose of (one
of) my medicines without
discussing this with my doctor.
(R)

N=0

N=7

15. It has happened (at least) once
that I was too late with filling a
prescription at the pharmacy.
(R)

N=4

N=3

16. I take my medicines every day.

N=7

N=0

17. It has happened (at least once)
that I did not start taking a
medicine that was prescribed by
my doctor. (R)

N=0

N=7

18. I sometimes take more
medicines than prescribed by
my doctor. (R)

N=0

N=7

Yes (true) is scored with a 1 and No (not true) is scored as a 0 unless the question is
labeled with an R for reverse coding.

